Real-world predictors of relapse in patients with schizophrenia and schizoaffective disorder in a large health system
Abstract Schizophrenia is often characterized by recurring relapses, which are associated with a substantial clinical and economic burden. Early identification of individuals at the highest risk for relapse in real-world treatment settings could help improve outcomes and reduce healthcare costs. Pri...
Main Authors: | Anne Rivelli, Veronica Fitzpatrick, Michael Nelson, Kimberly Laubmeier, Courtney Zeni, Srikrishna Mylavarapu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-02-01
|
Series: | Schizophrenia |
Online Access: | https://doi.org/10.1038/s41537-024-00448-2 |
Similar Items
-
Neurophysiological distinction between schizophrenia and schizoaffective disorder
by: Daniel H Mathalon, et al.
Published: (2010-01-01) -
Therapy of Schizoaffective Disorder and Paranoid Schizophrenia with Episodic Course
by: L. A. Ivanova, et al.
Published: (2019-05-01) -
Clinical factors affecting functioning in patients with schizophrenia or schizoaffective disorder
by: C. Neily, et al.
Published: (2022-06-01) -
Religious Coping Strategies for Religious Patients with Schizophrenia and Schizoaffective Disorder
by: E. Gedevani, et al.
Published: (2022-06-01) -
The use of technologies and social media in patients with schizophrenia and schizoaffective disorder
by: O. Elleuch, et al.
Published: (2022-06-01)